Join the Cotellic group to help and get support from people like you.
Cotellic News
Targeted Treatment Shrinks Rare Brain Tumors in Small Study
THURSDAY, July 13, 2023 – A targeted treatment has had unprecedented success in shrinking a rare brain tumor, according to clinical trial results. These tumors are papillary craniopharyngiomas...
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center
1-Nov-2022 – Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic®) for the t...
FDA Approves Cotellic (cobimetinib) for the Combination Treatment of Advanced Melanoma
November 10, 2015 – The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts...
Ask a question
To post your own question to this support group, sign in or create an account.